Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer
Condition: Pancreatic CancerInterventions: Biological: GVAX Pancreas; Biological: CRS-207; Drug: CyclophosphamideSponsors: Aduro BioTech, Inc.; Johns Hopkins UniversityActive, not recruiting - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2011 Category: Research Source Type: clinical trials